| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $256.4M | +13.0% |
| Cost of Revenue | $81.5M | +39.8% |
| Gross Profit | $174.9M | +3.7% |
| R&D Expense | $20.8M | +31.2% |
| SG&A Expense | $44.9M | +25.7% |
| Operating Income | $40.5M | -31.1% |
| Pre-tax Income | $37.5M | -42.2% |
| Income Tax | $8.8M | +6.9% |
| Net Income | $28.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.4M | +12.0% |
| Accounts Receivable | $314.3M | +9.5% |
| Current Assets | $503.5M | +9.3% |
| Total Assets | $642.2M | +16.7% |
| Current Liabilities | $302.0M | +13.1% |
| Total Liabilities | $330.0M | +12.6% |
| Stockholders' Equity | $312.2M | +21.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $87.2M | -1.7% |
| Capital Expenditures | $35.9M | +17.9% |
| Investing Cash Flow | -$81.4M | +15.9% |
| Financing Cash Flow | $4.0M | -56.9% |
| Free Cash Flow | $51.3M | -11.9% |
| -49.3% |
| EPS (Basic) | $0.55 | -51.3% |
| EPS (Diluted) | $0.50 | -50.0% |